Investors Research Corp - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 278 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
Investors Research Corp ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$744,401
-1.5%
48,1190.0%0.19%
+1.6%
Q2 2023$755,949
-8.5%
48,119
-4.0%
0.19%
-11.2%
Q1 2023$825,961
+5.6%
50,1190.0%0.22%
+1.4%
Q4 2022$781,856
+19.7%
50,119
-0.4%
0.21%
+6.0%
Q3 2022$653,000
-7.5%
50,3190.0%0.20%
-5.7%
Q2 2022$706,000
+5.2%
50,319
+7.4%
0.21%
+11.6%
Q1 2022$671,000
+44.9%
46,869
+38.0%
0.19%
+35.7%
Q4 2021$463,000
+17.8%
33,969
+41.7%
0.14%
+5.3%
Q3 2021$393,000
-2.5%
23,9660.0%0.13%
-4.3%
Q2 2021$403,000
-8.0%
23,9660.0%0.14%
-15.8%
Q1 2021$438,000
-3.9%
23,966
-4.3%
0.16%
-7.8%
Q4 2020$456,000
+3.9%
25,041
+1.8%
0.18%
-16.0%
Q3 2020$439,000
+2210.5%
24,591
+2262.2%
0.21%
+2030.0%
Q2 2020$19,000
+18.8%
1,0410.0%0.01%0.0%
Q1 2020$16,000
-23.8%
1,0410.0%0.01%0.0%
Q4 2019$21,000
+16.7%
1,0410.0%0.01%
+11.1%
Q3 2019$18,0000.0%1,0410.0%0.01%0.0%
Q2 2019$18,000
-14.3%
1,0410.0%0.01%
-18.2%
Q1 2019$21,0001,0410.01%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2022
NameSharesValueWeighting ↓
Adelphi Capital LLP 7,584,930$138,046,00026.79%
Glenview Capital Management 15,260,512$277,741,0006.37%
Paulson & Co. 11,295,846$205,584,0005.34%
GMT CAPITAL CORP 2,871,395$52,259,0003.72%
MANAGED ASSET PORTFOLIOS, LLC 966,643$17,593,0003.09%
TFG Asset Management GP Ltd 1,443,052$26,264,0001.76%
Mondrian Investment Partners LTD 3,274,660$58,944,0001.46%
Blackcrane Capital, LLC 35,236$641,0001.26%
Lumbard & Kellner, LLC 136,378$2,404,0000.95%
DAVIDSON INVESTMENT ADVISORS 509,800$9,278,0000.86%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders